Search Within

Laetitia A Borsu Valente

Formats
  1. Meeting Abstract (42)
  2. Journal Article (38)
  3. Guidelines (1)
Groups
  1. Department of Pathology and Laboratory Medicine (81)
  2. GSK Faculty (66)
  3. Tow Center for Developmental Oncology (TCDO) (61)
  4. Human Oncology and Pathogenesis Program (59)
  5. Department of Medicine (47)
  6. Solid Tumor Oncology Division (43)

More Groups

People
  1. Marc Ladanyi (56)
  2. Maria Arcila (36)
  3. Khedoudja Nafa (20)
  4. Michael Berger (17)
  5. Ryma Benayed (14)
  6. Ahmet Zehir (13)

More People

Years
  1. 2025 (3)
  2. 2024 (2)
  3. 2023 (6)
  4. 2022 (3)
  5. 2021 (2)
  6. 2020 (3)

More Years

Publications
  1. Journal of Molecular Diagnostics (21)
  2. Modern Pathology (8)
  3. Journal of Clinical Oncology (6)
  4. Laboratory Investigation (6)
  5. Clinical Cancer Research (5)
  6. Journal of Thoracic Oncology (5)

More Publications

Publishers
  1. Elsevier Science, Inc. (21)
  2. Nature Publishing Group (13)
  3. American Association for Cancer Research (11)
  4. Nature Research (8)
  5. American Society of Clinical Oncology (7)
  6. Elsevier Inc. (6)

More Publishers

Results (81)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next-generation sequencing of FFPE solid tumor specimens for clinical use
    Meeting Abstract

    Yelensky, R.; Wang, K.; Dogan, S.; Borsu, L.; Frampton, G.; Lipson, D.; Stephens, P.; Bastian, B.; Klimstra, D.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Massively parallel sequencing of cancer FFPE specimens matches diagnostic accuracy of methods in current clinical use and reveals additional actionable mutations
    Meeting Abstract

    Yelensky, R.; Dogan, S.; Borsu, L.; Frampton, G.; Lipson, D.; Bastian, B. C.; Klimstra, D. S.; Ladanyi, M.; Cronin, M.; Hedvat, C. V.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • An evaluation of next-generation sequencing for diagnostic use in cancer care
    Meeting Abstract

    Wang, K.; Yelensky, R.; Dogan, S.; Borsu, L.; Frampton, G. M.; Lipson, D.; Bastian, B.; Klimstra, D.; Ladanyi, M.; Stephens, P.; more...
    Journal of Molecular Diagnostics (2012)

    Fulltext@MSK | Save
  • IDH1 and IDH2 mutations in chondrosarcomas
    Meeting Abstract

    Nafa, K.; Agaram, N. P.; Borsu, L.; Schwartz, G.; Healey, J.; Ladanyi, M.; Hameed, M.
    Journal of Molecular Diagnostics (2012)

    Fulltext@MSK | Save
  • Comprehensive genomic characterization of squamous cell lung cancers
    Journal Article

    The Cancer Genome Atlas Research Network
    Nature (2012)

    Fulltext@MSK | Save
  • Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways
    Journal Article

    Shukla, N.; Ameur, N.; Yilmaz, I.; Nafa, K.; Lau, C. Y.; Marchetti, A.; Borsu, L.; Barr, F. G.; Ladanyi, M.
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Integrated genomic analyses of ovarian carcinoma
    Journal Article

    The Cancer Genome Atlas Research Network
    Nature (2011)

    Fulltext@MSK | Save
  • Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer
    Journal Article

    Welsbie, D. S.; Xu, J.; Chen, Y.; Borsu, L.; Scher, H. I.; Rosen, N.; Sawyers, C. L.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Haplotype analysis of bevacizumab-induced hypertension
    Meeting Abstract

    Frey, M. K.; Olvera, N.; Bogomolniy, F.; Dao, F.; Borsu, L.; Konner, J.; Barakat, R. R.; Dickler, M.; Levine, D. A.
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • WNK1 haplotypes and bevacizumab-induced hypertension
    Meeting Abstract

    Frey, M. K.; Olvera, N.; Bogomolniy, F.; Dao, F.; Borsu, L.; Konner, J. A.; Rizvi, N. A.; Barakat, R. R.; Dickler, M. N.; Levine, D. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save